Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

458 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world outcomes of unrestricted direct-acting antiviral treatment for hepatitis C in Australia: The South Australian statewide experience.
Haridy J, Wigg A, Muller K, Ramachandran J, Tilley E, Waddell V, Gordon D, Shaw D, Huynh D, Stewart J, Nelson R, Warner M, Boyd M, Chinnaratha MA, Harding D, Ralton L, Colman A, Liew D, Iyngkaran G, Tse E; Adelaide Liver Group. Haridy J, et al. Among authors: harding d. J Viral Hepat. 2018 Nov;25(11):1287-1297. doi: 10.1111/jvh.12943. Epub 2018 Jul 10. J Viral Hepat. 2018. PMID: 29888827
Cost effectiveness of treatment models of care for hepatitis C: the South Australian state-wide experience.
Ramachandran J, Kaambwa B, Muller K, Haridy J, Tse E, Tilley E, Altus R, Waddell V, Gordon D, Shaw D, Huynh D, Stewart J, Nelson R, Warner M, Boyd MA, Chinnaratha MA, Harding D, Ralton L, Colman A, Woodman R, Wigg AJ. Ramachandran J, et al. Among authors: harding d. Eur J Gastroenterol Hepatol. 2020 Oct;32(10):1381-1389. doi: 10.1097/MEG.0000000000001659. Eur J Gastroenterol Hepatol. 2020. PMID: 31895911
Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort.
Clark PJ, Valery PC, Strasser SI, Weltman M, Thompson AJ, Levy M, Leggett B, Zekry A, Rong J, Angus P, George J, Bollipo S, McGarity B, Sievert W, Macquillan G, Tse E, Nicoll A, Wade A, Chu G, Harding D, Cheng W, Farrell G, Roberts SK. Clark PJ, et al. Among authors: harding d. Dig Dis Sci. 2023 Jan;68(1):291-303. doi: 10.1007/s10620-022-07483-y. Epub 2022 May 13. Dig Dis Sci. 2023. PMID: 35552941 Free PMC article.
Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up.
Clark PJ, Valery PC, Ward J, Strasser SI, Weltman M, Thompson A, Levy MT, Leggett B, Zekry A, Rong J, Angus P, George J, Bollipo S, McGarity B, Sievert W, Macquillan G, Tse E, Nicoll A, Wade A, Chu G, Harding D, Cheng W, Farrell G, Roberts SK. Clark PJ, et al. Among authors: harding d. BMC Gastroenterol. 2022 Jul 11;22(1):339. doi: 10.1186/s12876-022-02416-5. BMC Gastroenterol. 2022. PMID: 35820850 Free PMC article.
Hepatitis C Virus Antiviral Drug Resistance and Salvage Therapy Outcomes Across Australia.
Wang DS, Phu A, McKee K, Strasser SI, Sheils S, Weltman M, Sellar S, Davis JS, Young M, Braund A, Farrell GC, Blunn A, Harding D, Ralton L, Muller K, Davison SA, Shaw D, Wood M, Hajkowicz K, Skolen R, Davies J, Tate-Baker J, Doyle A, Tuma R, Hazeldine S, Lam W, Edmiston N, Zohrab K, Pratt W, Watson B, Zekry A, Stephens C, Clark PJ, Day M, Park G, Kim H, Wilson M, McGarity B, Menzies N, Russell D, Lam T, Boyd P, Kok J, George J, Douglas MW. Wang DS, et al. Among authors: harding d. Open Forum Infect Dis. 2024 Mar 18;11(4):ofae155. doi: 10.1093/ofid/ofae155. eCollection 2024 Apr. Open Forum Infect Dis. 2024. PMID: 38651137 Free PMC article.
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.
Francque SM, Bedossa P, Ratziu V, Anstee QM, Bugianesi E, Sanyal AJ, Loomba R, Harrison SA, Balabanska R, Mateva L, Lanthier N, Alkhouri N, Moreno C, Schattenberg JM, Stefanova-Petrova D, Vonghia L, Rouzier R, Guillaume M, Hodge A, Romero-Gómez M, Huot-Marchand P, Baudin M, Richard MP, Abitbol JL, Broqua P, Junien JL, Abdelmalek MF; NATIVE Study Group. Francque SM, et al. N Engl J Med. 2021 Oct 21;385(17):1547-1558. doi: 10.1056/NEJMoa2036205. N Engl J Med. 2021. PMID: 34670042 Clinical Trial.
Gastrointestinal: Olmesartan-induced enteropathy.
Shahzad MA, Harding D, Ruszkiewicz A, Tran E, England G, Philpott H. Shahzad MA, et al. Among authors: harding d. J Gastroenterol Hepatol. 2018 Oct;33(10):1691. doi: 10.1111/jgh.14317. Epub 2018 Jul 2. J Gastroenterol Hepatol. 2018. PMID: 29968297 No abstract available.
458 results